Search research articles
Contact Us
Filters
Showing results (251-260 of 284) with videos related to
Page
of 29
Sort By:
Annals of the New York Academy of Sciences
|
May 31, 1993
Hormonal regulation of melanogenesis in mouse melanoma and in human melanocytes
B B Fuller, D Rungta, K Iozumi, et al.
Endocrinology
|
June 1, 1983
Effects of naloxone and an enkephalin analog on serum prolactin, cortisol, and gonadotropins in the chimpanzee
R E Gosselin, J Blankstein, D W Dent, et al.
The Surgical Clinics of North America
|
August 1, 1996
Penetrating cardiac injuries
J A Asensio, B M Stewart, J Murray, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 30, 2018
Patient and Dosimetric Predictors of Genitourinary and Bowel Quality of Life After Prostate SBRT: Secondary Analysis of a Multi-institutional Trial
Kyle Wang, Ronald C Chen, Brent L Kane, et al.
Transplantation Proceedings
|
September 2, 1998
Recipient and donor outcomes in living related and unrelated lobar transplantation
M L Barr, F A Schenkel, R G Cohen, et al.
Cryo Letters
|
October 26, 2023
The role of cryopreservation techniques in manufacturing, transport, and storage of Car-T therapy products
M Jandova, G N Stacey, M Lanska, et al.
Frontiers in Oncology
|
August 15, 2022
High Dose "HDR-Like" Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial
Donald B Fuller, Tami Crabtree, Brent L Kane, et al.
Clinical and Experimental Immunology
|
February 10, 2011
Smoking and periodontal disease: discrimination of antibody responses to pathogenic and commensal oral bacteria
L Hayman, M J Steffen, J Stevens, et al.
European Urology Oncology
|
June 4, 2019
Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes
Donald B Fuller, Aaron D Falchook, Tami Crabtree, et al.
American Journal of Clinical Oncology
|
June 21, 2016
A Pooled Analysis of Biochemical Failure in Intermediate-risk Prostate Cancer Following Definitive Stereotactic Body Radiotherapy (SBRT) or High-Dose-Rate Brachytherapy (HDR-B) Monotherapy
John V Hegde, Sean P Collins, Donald B Fuller, et al.
Page
of 29
Search research articles
Search
Showing results (251-260 of 284) with videos related to
Sort By:
Page
of 29
Annals of the New York Academy of Sciences
|
May 31, 1993
Hormonal regulation of melanogenesis in mouse melanoma and in human melanocytes
B B Fuller, D Rungta, K Iozumi, et al.
Endocrinology
|
June 1, 1983
Effects of naloxone and an enkephalin analog on serum prolactin, cortisol, and gonadotropins in the chimpanzee
R E Gosselin, J Blankstein, D W Dent, et al.
The Surgical Clinics of North America
|
August 1, 1996
Penetrating cardiac injuries
J A Asensio, B M Stewart, J Murray, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 30, 2018
Patient and Dosimetric Predictors of Genitourinary and Bowel Quality of Life After Prostate SBRT: Secondary Analysis of a Multi-institutional Trial
Kyle Wang, Ronald C Chen, Brent L Kane, et al.
Transplantation Proceedings
|
September 2, 1998
Recipient and donor outcomes in living related and unrelated lobar transplantation
M L Barr, F A Schenkel, R G Cohen, et al.
Cryo Letters
|
October 26, 2023
The role of cryopreservation techniques in manufacturing, transport, and storage of Car-T therapy products
M Jandova, G N Stacey, M Lanska, et al.
Frontiers in Oncology
|
August 15, 2022
High Dose "HDR-Like" Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial
Donald B Fuller, Tami Crabtree, Brent L Kane, et al.
Clinical and Experimental Immunology
|
February 10, 2011
Smoking and periodontal disease: discrimination of antibody responses to pathogenic and commensal oral bacteria
L Hayman, M J Steffen, J Stevens, et al.
European Urology Oncology
|
June 4, 2019
Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes
Donald B Fuller, Aaron D Falchook, Tami Crabtree, et al.
American Journal of Clinical Oncology
|
June 21, 2016
A Pooled Analysis of Biochemical Failure in Intermediate-risk Prostate Cancer Following Definitive Stereotactic Body Radiotherapy (SBRT) or High-Dose-Rate Brachytherapy (HDR-B) Monotherapy
John V Hegde, Sean P Collins, Donald B Fuller, et al.
Page
of 29